hematoporphyrin has been researched along with perfluoropentane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, X; Gao, X; Luo, J; Luo, Y; Pu, D; Wang, Q; Xu, D; Yan, S; Yong, L; Zhang, Y; Zou, J | 1 |
| Cao, Y; Chen, Q; Luo, Y; Qiao, B; Ran, H; Wang, X; Wang, Z; Yang, C; Zhang, L; Zhang, Y | 1 |
2 other study(ies) available for hematoporphyrin and perfluoropentane
| Article | Year |
|---|---|
Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Breast Neoplasms; Cell Proliferation; Combined Modality Therapy; Disease Models, Animal; Female; Fluorocarbons; Hematoporphyrins; High-Intensity Focused Ultrasound Ablation; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2019 |
Dual ultrasound-activatable nanodroplets for highly-penetrative and efficient ovarian cancer theranostics.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Female; Fluorocarbons; Folic Acid; Hematoporphyrins; Humans; Materials Testing; Nanoparticles; Ovarian Neoplasms; Particle Size; Surface Properties; Theranostic Nanomedicine; Ultrasonic Waves | 2020 |